FINAL - Dermatology Flashcards

1
Q

Largest organ in the human body

A

Skin
-Average adult: 2,800sq in
16% of total body weight
-Largest sensory organ

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Role of the pharmacist in managing patients w/dermatologic disorders

A

Pharmacists are often the first-line consult patient seeks
-Patients rely on pharmacists to know when to treat and when to refer
-Risks associated w/self-care
-Cost-savings
-Convenience

Must know how to guide patient with self-care
-Product selection
-Dressings
-Follow up

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

KEY PHARMACIST PROPERITES

A

Knowledge of vehicles and bases
Knowledge of commonly used terminology
Knowledge of drug-induced skin conditions
-Be able to identify common dermatologic lesions and rashes
-Know when to suggest self care or refer pts to PCP or dermatologist
-Know advantages and disadvantages of dermatologic products
-Advise pts on the proper use of dermatologic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What questions to ask

A

-Onset, duration, getting better or worse
-Which parts of the body are involved
-Isolated or symmetrical
-Symptoms (local vs systemic)
-Exposure to new drugs or irritants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

General guidelines when to refer

A

Multiple extensive burns
-Human or animal bites
-Multiple or extensive cuts, bruises or abrasions
-Rash that is extensive, weeping, or infected
-Tumors or growths
-Yellow skin
-Deep infection (cellulitis)
-Large blisters of unknown origins
-Exposed deep tissue, muscle, or bone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Cost of Rx dern products

A

2009-2019
-Many brand products have increased 100%-500%
-Many generic products have increased 100-200%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Application of topicals

A

Finger tip units

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Choice of bases

A

Combination of factors
-One factor may outweigh the others
Importance of working WITH patients

  1. Condition of the skin
    -Desired effect from the base
    -Dry the skin vs moisturize
    -Water-resistance vs washes right off
  2. Area of application
  3. Patient acceptability
  4. The nature of incorporated medication
    -Bioavailability
    -Stability
    -Compatibility
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Basic vehicles for dermatologic products

A

Ointments
Adv:
-Best for hydration
-Best for drug delivery
-Removes scales
Disadv:
-Greasy
-Low patient acceptance
(messy)
-Not ideal for hairy areas

Cream
Adv:
-Good for hydration
-Good for drug delivery
-Can apply to most areas: hairy, groin, face
-High patient acceptance

Lotion
Adv:
-Watered down creams
-Easy to apply
-Good patient acceptance
Disadv:
-Requires freq applications
-Not ideal for very dry skin

Gel
Adv:
-Excellent for EtOH soluble drugs
-Can apply to most areas: hairy, groin, face
-High patient acceptance - non greasy
Disadv:
-Can be drying

Solution; foam; spray:
Adv:
-Can apply to most areas
-Easy to apply in hairy and groin areas
-Not ideal for drug delivery
Disadv:
-Can be drying
-Not ideal for hydration
-Requires freq application

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Vehicles for topical prep

A

Hair bearing skin
-solution/spray
-foam
-gel
-cream

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Dry skin (Xerosis)

A

Common features
-Fall and winter
-Feet, lower legs
-Hands, elbows, face
-Rough, dry, scales, cracks
-Itching is common sx

Who is at risk?
-Elderly
Decreased activity of sweat and sebaceous glands
Very warm, dry environments
Frequent bathing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Dry Skin (Xerosis) tx

A

Emollients
-First line for itching
-Restores barrier and skin function
Agents for itching
Alter bathing habits

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Emollients ex

A

Vaseline
Aquaphor
Cetaphil
Nivea
Keri
Lubriderm
AmLactin
Eucerin
CeraVe

Ointments vs Creams, vs lotions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Agents to reduce itching

A

Menthol and camphor
-1/2-1%
-Create a sensation of cooling

Pramoxine
-1%
-Local anesthetic

Aluminum acetate
-0.2%
-Alter C-fiber nerve transmission

Hydrocortisone
-0.5% and 1%
-Anti-inflammatory

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Dermatitis

A

Inflammatory process of the upper two layers of skin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Dermatitis classifications

A

Acute
-Red patches or plagues
-Pebbly surface or blisters
Itching is intense
Ex:
Contact dermatitis
-Irritant cs Allergic
-Poison Ivy

Sub-acute
-Dry
-Less red
-Crusting; oozing
-Mild thickening
Itching is common, but less intense
Ex:
Atopic Dermatitis
-Eczema

Chronic
-Epidermal thickening
-Exaggerated skin markings
-Excoriations; fissures; scaling
Lichenification
-Less itching
Ex:
-Stasis dermatitis
-Any long standing acute or sub-acute dermatitis
-Irritation and trauma worsen itching

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Acute contact Dermatitis

A

Look at pattern
Look at part of body involved
-Main sx - itching
Two types:
-Allergic
-Irritant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

General tx principles of dermatitis

A

Stop the itch-scratch cycle
-Must understand patient’s personality, social and domestic conditions

Ability to carry out tx

No one best therapy for ever pt

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Acute contact dermatitis

A

Irritant
-Non-immunologic reaction to frequent contact with everyday substances
-More common than allergic
-Reaction within a few hours

Common irritants
-Metals
-Cosmetics
-Adhesives

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Contact Dermatitis - Poison Ivy

A

Direct exposure
-Broken plant
-Resin - 2 weeks

Indirect exposure
-Clothing, dog, smoke
-Does not spread from lesions

Prevention is key
Ivy Block
-Protectant; barrier
-Re-apply every 4 hours

Dermatitis occurs 24-48 hours after exposure
Pruritis is intense
-Secondary infections

Wash skin and nails within 10 minutes
-Wash clothing as well

Topical therapy OK if <10% BSA involved

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Poison Ivy tx

A

Treatment options for limited rash??
-Remove source
-Calamine lotion
-Topical antihistamines
-Oral antihistamines
-Topical corticosteroids vs Oral Corticosteroids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Tx of acute dermatitis - MOA of topical corticosteroids

A

Anti-inflammatory
-Increase expression of anti-inflammatory genes and indirectly inhibit inflammatory transcription factors, such as NFkb, to decrease the expression of pro-inflammatory genes

Anti-Miotic
-Inhibits cell proliferation

Immunosuppressive
-Inhibition of humoral factors involved in the inflammatory response

Apply bid to qid *3-14 days
-Varies w/vehicle
-Always treat at least 1 day beyond resolution

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Tx of acute dermatitis - Corticosteroids

A

Avoid dose packs
-Only tx for 6days; need MINIMUM tx of 10-14 days
-Do not provide tx for long enough period of time

-Start at prednisone 40-60mg per day; taper every 3 days
-Minimum of 10-14 days of tx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Tx of acute dermatitis - Systemic Therapy

A

Non-sedating antihistamines
-Loratadine (claritin)
-Desloratadine (Clarinex)
-Fexofenadine (Allegra)

Sedating antihistmaines
-Diphenhydramine (Benadryl)
-Cetirizine (Zyrtec)
-Hydroxyzine (Atatrax) =RX
Doxepin = RX

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Atopic Dermatitis
Most common form of **eczema** Usually presents in infancy 1 in 5 children 1 in 12 adults **80% mild; 20% mod-severe** Significant QOL issues -Sleep -Depression, anxiety, productivity
26
Atopic Triad
**Atopic march** - Often first disease of atopic allergic triad to be observed -50-75% also develop allergic rhinitis and or asthma **Atopic Dermatitis Allergic rhinitis Asthma**
27
Atopic Dermatitis
**Pruritis** -Symmetrical red papules or plaques -Scaling excoriations **Overall dryness of skin** -Redness and inflammation -History of allergic disease -Risk of 2nd infection
28
Atopic Dermatitis age presentations
**Infant** -**Red, papular skin rash on cheeks and skin** -Lesions often crust over time -**lesions later appear on neck, trunk and groin** -Itching often results in irritability **Child** **Face, neck, flexural creases of arms and legs** -Skin often appears dry, flaky, rough, cracked, and may bleed from scratching -Sleep disturbance is common -Greater risk of secondary skin infections **Adult** -Hands and neck** **Flexor surfaces of the arms and legs** -Excoriation and lichenification from chronic scratching -Intense itching; sleep disturbance; Altered QOL; depression
29
Atopic Dermatitis Triggers
Allergens Chemicals Bathing **Detergents** Soaps Smoke Dust **Infections**
30
**Stepwise mgmt of atopic dermatitis**
**Non-pcol measures** -Lukewarm/tepid baths -**Emollients** -Eliminate irritants; modify environment; avoid triggers -Trim fingernails; Non-irritating clothing **Topical Therapy** -Topical corticosteroids (TCS) -Topical calcineurin inhibitor therapy -Topical JAK inhibitor -Strength/duration of use based on severity **Systemic therapy** -Phototherapy -Oral immunosuppressant therapy -Oral JAK inhibitors -Injectable biologic agents
31
**Stepwise mgmt of moderate-to-severe atopic dermatitis**
**Acute flares** -**Moderate to severe**: medium potency TCS BID for up to 3 days beyond CL of lesions **Refractory** **Refractory to topical agents or widespread lesions**: Phototherapy or oral immunosuppressive therapy **Inadequate response to all therapies**: consider emerging biologic agents **Maintenance therapy** **Moderate to severe** Basic measures plus daily application of low-potency TCS or 2-3 times weekly application of TCS or other topical anti-inflammatory agent **Written action plan**
32
Topical corticosteroids: Choice of vehicle based upon:
Location of lesions Type of lesion Severity of lesion/degree of inflammation Degree of skin penetration desired
33
Topical corticosteroids cont
Classified according to potency, which corresponds to **anti-inflammatory activity** and vasoconstrictive potency -Very-high-high-Mid-low (Grades I to VII) -Vehicle impacts delivery **and** potency of corticosteroids -Only 2% absorbed when applied to normal **intact** skin -**Occlusion enhances penetration** -Increases penetration up to 10X
34
Topical corticosteroids SE
-Thinning of skin -Dilated blood vessels -Increased bruising -Skin color changes -Risk of HPA suppression w/long-term use of high potency agents -Development of tolerance (tachphylaxis)
35
Topical corticosteroids ex based on classification
Very high potency: Class I **Betamethasone** dipropionate ointment Comments: -Used for very severe lesions and on thickened skin when max penetration is needed -**DO NOT USE ON FACE** -Avoid using super potent agents for **>2 weeks** Limit to no more than 50g per week High potency class 2 **Betamethasone dipropionate Lotion** (Diprolene) Comments: -Used for very severe lesions and on thickened skin when max penetration is needed -**DO NOT USE ON FACE** -Avoid using super potent agents for **>2 weeks** Limit to no more than 50g per week Mild potency classes 3-5 **Betamethasone dipropionate lotion (Diprolene) Comments: -Used on most skin surfaces for exacerbations -Moderate anti-inflammatory effect -Safer for longer usage than high potency Low potency Classes 6-7 -Hydrocortisone (Cortaid) -Desonide (Desonate) Comments: -Use on face, groin, genitals, axilla -Mild anti-inflammatory effect -Safest for long-term maintenance use
36
Topical Calcineurin Inhibitors
MOA: blocks pro-inflammatory cytokine genes **Primecrolimus and tacrolimus** **CAN BE USED ON ANY AREA** -Equivalent to mid-potency corts -No risk of atrophy -Few side effects - burning $$$
37
Topical Calcineurin inhibitors stats
**Now considered 2nd line treatment** -Intermittent use only -Recent concern regarding long-term use -Risk of malignancies -Risk of resp infect in children <2 yrs
38
Crisaborole 2% ointment
Phosphodiesterase- Inhibitor (non-steroidal) **Alternative to TCS and TCIs** -steroid phobia Mild or moderate AD BID for 28 days $619-$735
39
Ruxolitinib
**Opzelura 1.5% cream** -Mild to moderate atopic dermatitis -Not well controlled with other therapies -MOA: JAK inhibitor Mediates signaling of cytokines -Apply a thin layer BID up to 20% BSA -Short term use -Max of 60g per week Avoid in immunocompromised pts
40
Upadacitinib
Rinvoq -Moderate to severe atopic dermatitis Not well controlled with other therapies -MOA: JAK inhibitor Mediates signaling of cytokines and growth factors -15 mg - 30 mg PO once daily Well tolerated Higher Rates of major CV events and thrombosis
41
Dupilumab
Dupixent -First biologic indicated for mod-severe AD Not well controlled with other therapies **MOA: Human monoclonal antibody against IL-3 receptor alpha** Inhibits signaling of IL-4 and IL-3 (Th2 cytokines) -600mg initially, then 300mg SC q2 Weeks -Well tolerated $37,00 per year -Specialty pharmacy - expanded indication Tralokinumab -Adbry - recently approved
42
Acne - General information
**Definition**: A chronic inflammatory disease of the sebaceous glands and hair follicles of the skin characterized by comedones, papules, and pustules **Affects 90% of the adolescent population** -Corresponds to increased **androgen** production 80% of patients with acne are between **12-30 years old** -Males more severe during puberty -Females more severe during adulthood
43
**Factors that exacerbate acne**
**Oil based cosmetics Emotional stress Irritation/Physical pressure Drugs** -**Androgenic steroids** -Corticosteroids -Lithium -Anti-epilepitcs (phenytoin) -Tuberculostatic drugs -OCs
44
Pathophysiology of acne
Keratinous obstruction of sebaceous follicle outlet -Traps sebum -**Comedone** - hair follicle plugged with sebum, keratin and dead skin -Bacterial colonization in **trapped sebum**
45
Pathophysiology bacteria
Propionibacterium acnes - naturally colonize the skin and sebaceous glands -Proliferates in sebum environment -Bacteria **converts** TG to FFA which irritates local cell resulting in inflammation
46
Patho can be divided by two classes
**Non-inflammatory** 1. white heads 2. Black heads **Inflammatory** 1. Papules 2. Pustules 3. Ruptured Contents
47
Secondary Lesions
Excoriations Erythematous macules Hyperpigmented macules **Scars**
48
Treating complication
Dermabrasion Chemical peels -70% glycolic acid Laser resurfacing **$$$**
49
Goals of therapy
**Long-term control** -Relieve discomfort -Improve skin appearance -Minimize physiological stress **Prevent scars**
50
MOA of acne therapy
-Antimicrobial -Anti-inflammatory -Decrease sebum production -Keratolytic Compounds that break down the outer layers of the skin; decrease the thickness; and promote sloughing -Salicylic acid; urea; alpha-hydroxy acids Comedolytic -A product or medication that inhibits the formation of comedones -Tretinoin; aldapalen; azelaic acid
51
Treatment - all patients
Follow a regular skin cleansing regimen using a mild facial soap **BID** **Minimize** the use of products that cause irritation or stinging (aftershave, alcohol based cleansers) Use tepid, **not hot** water to clean affected areas **NO QUICK FIX** - weeks to months
52
Tx of **Comedonal, noninflammatory acne (mild) **
-First line: ** Topical retinoids** -Alt: Benzoyl peroxide (BP) Azelaic acid (lower strengths
53
Tx of Mild-moderate papulopustular inflammatory acne
First line: -**Adapalene + BP or -Clindamycin +BP** Alt: -Alternative retinoids -Adapalene + Oral antibiotics (OA)
54
Tx: Severe papulopustular or moderate nodular acne
First line **Oral isotretinoin** Alt: OA + Adapalene OA + adapalene +BP OA + Azelaic acid OA + Oral antiandrogens Oral antiandrogens + topicals
55
Tx of nodular or conglobate acne
First line **Oral isotretinoin** Alt: -OA + Azelaic acid Other topical agents or oral antiandrogens can be substituted for AA
56
Maintenance therapy acne
First line **Adapalene** Alt: -Tazarotene -Tretinoin -Azelaic acid -Benzoyl peroxide
57
Topical therapy: Adapalene (Differin)
Formulation: -Gel -Cream -Solution MOA: -Retinoid -Regulate epithelial cell growth **Daily at hs** Burning/stinging
58
Topical therapy: Tazorotene (Tazorac)
Formulation: -Cream -Gel MOA: -Retinoid Daily start lower strength very drying category X
59
Topical therapy: Tretinoin (Retin-A)
Formulation: -Cream -Gel -Solution MOA: -Retinoid **Daily at hs** sting, burn Dryness Photosensitivity 4-6 weeks until improvement
60
Topical therapy: Azelaic acid (Azelex)
Formulation -Cream MOA: Antibacterial Keratolytic Adjunct Well tolerated
61
Topical therapy: Benzoyl Peroxide (Oxy-10)
Formulation: -Gel -Cream -Lotion MOA: -Antibacterial -Comedolytic/keratolytic -Anti-inflammatory **BID** -Dry skin/irritation Can bleach skin/hair Start lower strength Avoid contact with clothin
62
Topical therapy: Clindamycin (Cleocin T)
Formulation: -Gel -Solution -Lotion MOA: Topical Antibiotic **Daily or BID**
63
Topical therapy: Erythromycin (Generic)
Formulation: -Gel -Solution Topical Antibiotic **BID** Expires in 30 days
64
Topical therapy: Clindamycin +BP (BenzaClin DUAC)
Formulation: -Cream Topical antibiotic Limits resistance
65
Adverse effects of topical agents
**Adapalene has the least** Tretinoin has the most Erthema Scaling Burning Flare Resistance HEAVY in antibiotics ONLY
66
Combination productions
Clindamycin + Benzoyl Peroxide -Duac Adapalene + Benzoyl Peroxide -Epiduo Forte **Most combo products are expensive!! Most insurances will not cover combo, but may cover individual ingredients**
67
Oral antibiotics
**Minocycline; Doxycycline; Erythromycin; Azithromycin; TMP/SMX **Decreased bacteria and inflammation** -weeks to see improvement **MOST EFFECTIVE WHEN INFLAMMATION PRESENT** -Risk of allergy, photosensitivity, GI upset, thrush -Risk of resistance developing (Limit to 6-8 weeks if possible)
68
Oral Anti-androgen therapy: Hormone tx
Low dose oral contraceptives Spironolactone **Ideal for females whos acne flares during menstrual cycle** -Decreases androgen Topical hormone -**Clascoterone 1% Cream** -Androgen receptor inhibitor May be used in males and females Applied BID Local erythema most common SE
69
Treatment: Severe acne
**Isotretinoin** -**Used for severe acne or when patients have failed other treatments or when it relapses soon after d/c other therapies** Vitamin A derivative **$393** - good rx Provides resolution in 80% of cases Reduces sebum production and shrinks sebaceous glands
70
Isotretinoin dosing
**0.5-2mg/kg/day in 2 doses (with food) for 15-20 weeks** **Acne will get worse before it gets better** -If acne flares after > 2 months off tx, a 2nd course may be used -Effectiveness increases with **higher doses**
71
Isotretinoin Adverse effects
Skin: -Dry skin -Dry eyes and nose -Dry lips -Hair shedding -Peeling of palms and soles -Photosensitivity MSK -Back pain -Arthralgias -Myalgias -Fatigue -Risk of osteoporosis -Delayed bone healing Labs: -Elevated AST/ALT -Elevated chol and triglycerides Other **Category X** hA Mood changes Night blindness **Depression/suicide**
72
Monitoring of patients on isotretinoins
AVOID pregnancy Do not take vitamin A sup Use moisturizer, lip balm, and artificial tears use sunscreen Take with food
73
IPledge program
Can only dispense 30 day supply Females must have negative pregnancy test every month to be on therapy
74
Tx follow up
For any pt with acne: -2-6 months will be necessary to determine if a regimen has been successful Lengthening acne free periods is key
75
Rosacea - General info
A common chronic progressive inflammatory dermatosis based on **Vascular instability** Characterized by **facial flushing/blushing** facial erythema, papules, pustules and **telangiectasia** Ages 25 and 70 years People with fair complexions Women > men Chronic, persisting for years with periods of exacerbation and remission
76
Subtypes of Rosacea
**Telangiectactic** -Visibly dilated blood vessels -Very red skin **Papulopustular** -Resembles acne **Phytmatous** -Enlarges sebaceous glands -**Especially the nose** -More common in males **Ocular** -Watery eyes -Bloodshot eyes
77
Trigger factors
Foods Temp Weather Beverages Medical conditions Emotional influences Physical exertion Skin products **Drugs** -**Vasodilators** -Topical corticosteroids -Nicotinic acid -ACE inhibitor -Calcium channel blockers -Statins
78
Tx: Lifestyle mods
**Avoid triggers** -avoid excessive exposure to the sun -Use mild soaps and cleansers -Stress adherence to topical meds Topical meds should be allowed to penetrate the skin for **5-10 min** before applying make-up
79
Med treatment of rosacea
**Mild** -Avoid triggers -Topical antibiotics (metronidazole) -Topical retinoids **Moderate** -Oral antibiotics -Topical retinoids **Severe** -Oral isotretinoin -Laser treatments
80
Tx of Rosacea; topical antibiotics and retinoids
Topical Antibiotics: **Metronidazole 1%** cream; gel; lotion **Tx of choice** - apply bid -Clindamycin Sulfur Topical retinoids **Azelaix acid** - Finacea Gel 15% antibacteral
81
New tx for Rosacea: **Brimonidine** (Mirvasco) 33%
Alpha-2 adrenergic agonist -**Tx of persistent facial erythema** Ophthalmic drops for ocular rosacea
82
Psoriasis basic info
**Thickened red patches covered by silver-white scales** 2% of us population Onset usually prior to 40 y/o
83
Psoriasis classification:
**Limited** -<5% BSA **Generalized** -Moderate 5-10% BSA **Severe** >10% BSA 80% of pts have mild to moderate 20% have severe disease
84
Psoriasis Triggers
**Stress** Cold environment Injury infection smoking Drugs (NSAIDs, ACE, Lithium) Diet
85
Goals of therapy Psoriasis
Decrease symptoms. % of BSA affected **Improve QOL** Reduce inflammation and slow down rapid skin cell division **Prolong periods between exacerbations**
86